First Squawk

China targets more Japanese companies with export controls-FT

UK’s Bridgepoint buys real estate unit in $1.4bn bet on US property-FT

Korea’s Chips Rally Is Driving Its Stock Market Into a Danger Zone-WSJ

AstraZeneca is set to pay Daiichi Sankyo $25 million after receiving EU approval.

Foreigners recorded net sales of 7.7 trillion won in KOSPI stocks on Monday, marking a record high.

Iran’s Deputy Foreign Minister Gharibabadi announced on X that he attended the inaugural Iran-Oman committee meeting on the Strait of Hormuz.

AstraZeneca PLC announced EU approval of Enhertu for HER2-positive solid tumour indications.

Japan’s Nikkei share average wiped out declines and was last flat.

Australia’s ASX 200 ended the session 0.7% higher at 8,823.40 points.

SK Hynix urged the development of strong education systems for the workforce in the southwest.

Toyota May global sales drop 7.2%, down for 4th month, on weak China demand-KYODO

SWEDEN TRADE BALANCE (SEK) MAY: 2.9B (PREV -7.3B)

AstraZeneca PLC announced that Datroway is recommended for EU approval in TNBC treatment.

Japan’s Nikkei index reduced losses, last trading 0.1% lower.

Shares of SK Hynix recovered, wiping out early losses of 5.8% and moving into positive territory.

Samsung Electronics Chairman Lee said the company’s robot investment will be focused in Gumi, North Gyeongsang.

Samsung Electronics Chairman Jay Y. Lee said the firm intends to build an HBM chip fab in the Chungcheong region.

Samsung Electronics Chairman Jay Y. Lee said Gwangju will be positioned as a base for chip manufacturing.

IPSEN TO BUY KARTOS THERAPEUTICS FOR UP TO $1.75 BILLION-WSJ

South Korea expects around 550 trillion won of investment for developing AI data centres, the government said.